Twitter
youtube
Discord
Contact us
Menu
Forums
New posts
Trending
Rules
Explore
Bioenergetic Wiki
Bioenergetic Life Search
Bioprovement Peat Search
Ray Peat Interviews by Danny Roddy
Master List: Ray Peat, PhD Interviews & Quotes by FPS
Traveling Resources
Google Flights
Wiki Voyage
DeepL Translator
Niche
Numbeo
Merch
Log in
Register
What's new
Search
Search
Search engine:
Threadloom Search
XenForo Search
Search titles only
By:
New posts
Trending
Menu
Log in
Register
Navigation
More options
Light/Dark Mode
Contact us
Close Menu
Forums
Information
World News
Growing prescriptions help push CVS past Q2 expectations
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="WPLG" data-source="post: 59145" data-attributes="member: 158"><p>CVS Health thumped second-quarter expectations and hiked its full-year forecast as growing prescription claims and COVID-19 test kits sales helped to offset a drop in vaccinations.</p><p></p><p>The drugstore chain, pharmacy benefit manager and insurer said Wednesday that it now expects to post adjusted earnings of $8.40 to $8.60 per share this year, a 20-cent hike at both ends of the range from its previous forecast.</p><p></p><p>Analysts forecast, on average, earnings of $8.35 per share, according to FactSet.</p><p></p><p>In the second quarter, adjusted earnings totaled $2.40 per share as total revenue rose 11% to $80.64 billion.</p><p></p><p>Analysts predicted earnings of $2.18 per share on $76.41 billion in revenue.</p><p></p><p>CVS operates one of the nation’s largest drugstore chains with nearly 10,000 retail locations. It also runs prescription drug plans for big clients like insurers and employers through a large pharmacy benefit management business.</p><p></p><p>It also provides health insurance for more than 24 million people through its Aetna arm.</p><p></p><p>Shares of CVS Health Corp., based in Woonsocket, Rhode Island, climbed 2% before the opening bell.</p><p></p><p><a href="https://www.local10.com/business/2022/08/03/growing-prescriptions-help-push-cvs-past-q2-expectations/" target="_blank">Continue reading...</a></p></blockquote><p></p>
[QUOTE="WPLG, post: 59145, member: 158"] CVS Health thumped second-quarter expectations and hiked its full-year forecast as growing prescription claims and COVID-19 test kits sales helped to offset a drop in vaccinations. The drugstore chain, pharmacy benefit manager and insurer said Wednesday that it now expects to post adjusted earnings of $8.40 to $8.60 per share this year, a 20-cent hike at both ends of the range from its previous forecast. Analysts forecast, on average, earnings of $8.35 per share, according to FactSet. In the second quarter, adjusted earnings totaled $2.40 per share as total revenue rose 11% to $80.64 billion. Analysts predicted earnings of $2.18 per share on $76.41 billion in revenue. CVS operates one of the nation’s largest drugstore chains with nearly 10,000 retail locations. It also runs prescription drug plans for big clients like insurers and employers through a large pharmacy benefit management business. It also provides health insurance for more than 24 million people through its Aetna arm. Shares of CVS Health Corp., based in Woonsocket, Rhode Island, climbed 2% before the opening bell. [url="https://www.local10.com/business/2022/08/03/growing-prescriptions-help-push-cvs-past-q2-expectations/"]Continue reading...[/url] [/QUOTE]
Loading…
Insert quotes…
Verification
Post reply
Forums
Information
World News
Growing prescriptions help push CVS past Q2 expectations
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top